Approvals/HSA/PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G

Approved

THERAPEUTIC

PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G

Approval Date: Jul 31, 2017
Approval ID: da5910e34b8d9f9d
Company: LABESFAL - LABORATORIOS ALMIRO S.A. (FRESENIUS KABI GROUP) - PORTUGALFRESENIUS KABI IPSUM SRL (VILLADOSE PLANT) (INTERMEDIATE) (ITALY)
Type: Therapeutic

Approval Id: da5910e34b8d9f9d
Drug Name: PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G
Product Name: PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G
Approval Number: SIN15308P
Approval Date: 2017-07-31
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder: FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: INJECTION, POWDER, FOR SOLUTION
Route Of Administration: INTRAVENOUS
Atc Code: J01CR05
Atc Item Name: piperacillin and beta-lactamase inhibitor
Pharma Manufacturer Name: FRESENIUS KABI (SINGAPORE) PTE LTD
Company Detail Path: /organization/fresenius-kabi-singapore-pte-ltd

Tazobactam sodium sterile 536.6 mg corresponding to Tazobactam

0.5g

Piperacillin sodium sterile 4.170 g corresponding to Piperacillin

4.0 g

PIPERACILLIN SODIUM STERILE 4.17 G CORRESPONDING TO PIPERACILLIN

4 G

TAZOBACTAM SODIUM STERILE 536.6 MG CORRESPONDING TO TAZOBACTAM

0.5 G

Approved

Agency

HSA

Country

🇸🇬

Approval Date

Jul 31, 2017

Approval ID

da5910e34b8d9f9d

Type

Therapeutic